New gel injections aim to smooth cheek wrinkles
NCT ID NCT07344584
First seen Jun 24, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This pilot study will test the safety and effectiveness of two injectable gels, GP0122 and GP0124, for reducing lines and wrinkles in the cheek area. About 60 adults with moderate to severe cheek wrinkles will receive the treatment and be followed for 12 months. The main goal is to check for side effects and pain, with secondary goals looking at wrinkle improvement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Injectable gel (GP0122 and GP0124)
- What this could lead to
- If successful, this could lead to a new, safe option for reducing cheek wrinkles.
- What could go wrong
- This is a small, early pilot study with only 60 participants. It focuses on safety first, so effectiveness is not yet proven. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WRINKLE REDUCTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Galderma Investigational Site #7049
Vancouver, V6H4E1, Canada
-
Galderma Investigational Site #8162
Woodbridge, L4L 8E2, Canada
-
Galderma Investigational Site #8379
Burlington, L7N3N2, Canada
-
Galderma Investigational Site #8688
Vancouver, V5ZRE1, Canada
-
Galderma Investigational Site #8689
Toronto, M543N8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.